Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 313 - 320 of 12011 results
Telephone and Texting Compliance News: Regulatory Update — Robocalling Proceedings Potentially Impacted by Regulatory Freeze
January 31, 2025| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — Eleventh Circuit Knocks Out One-to-One Consent
January 31, 2025| Article| Viewpoint
I Heart FTC: Proposed New York Bill Would Continue Biden FTC’s Antitrust Vision and Policies
January 30, 2025| Alert| Viewpoint
DeepSeek’s Rise Creates Urgency and Uncertainty for President Trump’s AI Agenda — AI: The Washington Report
January 30, 2025| Article| Viewpoint
Avoiding the Provisional Application Filing Pitfall of Narrowed Claim Interpretation
January 29, 2025| Article| Viewpoint
Sooner the Better: Employers in Canada Should Really Review Their Termination of Employment Clauses
January 29, 2025| Blog| Viewpoint
Employer Win on FLSA Exemption Issue – Heightened Pleading Standard Rejected by High Court
January 28, 2025| Blog| Viewpoint
Will Extending Tax Cuts Cost Retirement Savers?
January 28, 2025| News
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|